| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(90)92269-N |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:014067369092269N?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:014067369092269N?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1699098 |
| P2093 | author name string | S. Moncada | |
| M. H. Yacoub | |||
| A. H. Chester | |||
| G. S. O'Neil | |||
| S. Tadjkarimi | |||
| P2860 | cites work | Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo | Q69439357 |
| Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110 | Q69988639 | ||
| Isolated perfused rabbit coronary artery and aortic strip preparations: the role of endothelium-derived relaxant factor | Q71012571 | ||
| Role of endothelium-derived nitric oxide in the regulation of blood pressure | Q28242958 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta | Q34555162 | ||
| Endothelium-dependent hyperpolarization of canine coronary smooth muscle | Q35755374 | ||
| Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery | Q35755922 | ||
| Endothelial modulation of coronary tone | Q39632210 | ||
| Endothelium-derived relaxing factor is an endogenous vasodilator in man. | Q41903464 | ||
| Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation | Q42051498 | ||
| A comparison of basal and agonist-stimulated release of endothelium-derived relaxing factor from different arteries | Q42219130 | ||
| Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans | Q43611687 | ||
| Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. | Q50894729 | ||
| Endothelium-dependent relaxation in isolated human arteries and veins. | Q50900445 | ||
| NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? | Q54355366 | ||
| Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries | Q69015514 | ||
| Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man | Q69375610 | ||
| P433 | issue | 8720 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 897-900 | |
| P577 | publication date | 1990-10-01 | |
| 1990-10-13 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries | |
| P478 | volume | 336 |
| Q33848393 | A pivotal role of nitric oxide in endothelial cell dysfunction. |
| Q71879928 | Aging-associated endothelial dysfunction in humans is reversed by L-arginine |
| Q53964063 | Assessment of human long saphenous vein function with minimally invasive harvesting with the Mayo stripper. |
| Q37728774 | Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus |
| Q73384998 | Attenuation of hypothermia-induced platelet activation and platelet adhesion to artificial surfaces in vitro by modification of hemoglobin to carry S-nitric oxide and polyethylene glycol |
| Q42455383 | Basal and induced nitric oxide and cGMP productions are decreased in senescent cultured rat articular chondrocytes |
| Q42457768 | Basal nitric oxide production contributes to membrane potential and vasotone regulation of guinea pig in vitro spiral modiolar artery |
| Q71844425 | Bradykinin-Induced Vasodilation Is Impaired at the Atherosclerotic Site but Is Preserved at the Spastic Site of Human Coronary Arteries In Vivo |
| Q64987260 | Circulatory dysfunction in NAFLD--which is first, which is last, and what do we do in between? |
| Q33811458 | Coronary artery blood flow: physiologic and pathophysiologic regulation |
| Q50937183 | Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the severity of the culprit lesion. |
| Q41943715 | Cyclosporin treatment and nitric oxide release in human coronary arteries |
| Q33611345 | Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries |
| Q35605782 | Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase |
| Q38519676 | Effect of Uwhangchungsimwon on expression of nitric oxide synthase and vascular cell adhesion molecule-1 in human endothelial cells |
| Q73339239 | Effect of cardioplegia infusion pressure on coronary artery endothelium and cardiac mechanical function |
| Q40752888 | Effects of fish oil on risk factors for cardiovascular disease. Minireview based on a doctoral thesis |
| Q41667835 | Effects of glyceryl trinitrate tolerance on vascular responsiveness to constrictor agents in bovine isolated coronary artery |
| Q33612056 | Effects of vasoactive neuropeptides on human saphenous vein |
| Q40421153 | Elucidation of the role of plaque instability and rupture in acute coronary events |
| Q40582611 | Endogenous mediators and thrombophilia |
| Q40405195 | Endogenous nitric oxide in cardiovascular disease and transplantation |
| Q36691847 | Endogenous nitric oxide: physiology, pathology and clinical relevance |
| Q41122235 | Endothelial function in chronic congestive heart failure |
| Q33815804 | Endothelial nitric oxide in humans in health and disease. |
| Q73176780 | Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO(-)) |
| Q37392083 | Endothelium-derived relaxing factor and the pulmonary circulation |
| Q34170380 | Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension |
| Q43817639 | Enteric-release glyceryl trinitrate in active Crohn's disease: a randomized, double-blind, placebo-controlled trial |
| Q44000227 | Estriol retards and stabilizes atherosclerosis through an NO-mediated system |
| Q36329836 | Evidence for heterogeneity of endothelin receptor distribution in human coronary artery |
| Q35565928 | Evidence of partially preserved endothelial dilator function in diseased coronary arteries |
| Q71398624 | Explanted vein grafts with an intact endothelium demonstrate reduced focal expression of endothelial nitric oxide synthase specific to atherosclerotic sites |
| Q72395352 | Functional comparison between the human inferior epigastric artery and internal mammary artery. Similarities and differences |
| Q44367158 | High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser1177 phosphorylation in human aortic endothelial cells. |
| Q54103479 | In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. |
| Q42464723 | Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside |
| Q73327038 | Increased endogenous nitric oxide production induced by physical exercise in peripheral arterial occlusive disease patients |
| Q74787732 | Increased release of nitric oxide in ischemic hearts after exercise in patients with effort angina |
| Q71126173 | Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity |
| Q41022241 | Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes |
| Q40865183 | Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line. |
| Q41822901 | Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats |
| Q40405209 | Interactions between endothelial secretogogues |
| Q35871050 | Iron-sulphur cluster nitrosyls, a novel class of nitric oxide generator: mechanism of vasodilator action on rat isolated tail artery |
| Q34772312 | Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism |
| Q73146792 | Morphometric study of the right gastroepiploic and inferior epigastric arteries |
| Q42479848 | NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction |
| Q70928358 | Nitric oxide |
| Q77227013 | Nitric oxide and endothelin in the development of cardiac allograft vasculopathy. Potential targets for therapeutic interventions |
| Q55331921 | Nitric oxide and pulmonary arterial hypertension. |
| Q36628207 | Nitric oxide function in atherosclerosis |
| Q40405159 | Nitric oxide in cardiovascular diseases |
| Q40405202 | Nitric oxide-based possibilities for pharmacotherapy |
| Q28345869 | Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system |
| Q35015295 | Oxidant injury, nitric oxide and pulmonary vascular function: implications for the exercising horse |
| Q41051281 | Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages |
| Q73224116 | Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man |
| Q24313558 | Permissive role of nitric oxide in endothelin-induced migration of endothelial cells |
| Q34793673 | Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor. |
| Q28366585 | Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery |
| Q35599893 | Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina |
| Q35217622 | Regulation of the cerebral circulation by endothelium |
| Q67476724 | Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart |
| Q41327949 | The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications |
| Q51537374 | The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidaemic rabbits. |
| Q36500200 | The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems |
| Q40662541 | The megakaryocyte platelet system and vascular disease |
| Q34516431 | The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough |
| Q29547827 | The pathogenesis of atherosclerosis: a perspective for the 1990s |
| Q77291990 | The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces |
| Q41852095 | The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit |
| Q37552653 | Tissue injury caused by deposition of immune complexes is L-arginine dependent |
| Q57791545 | Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication |
| Q36437841 | Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia. |
| Q42810675 | Vascular inducible nitric oxide synthase gene therapy: requirement for guanosine triphosphate cyclohydrolase I. |
| Q36359845 | Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem |
Search more.